Abraxane in Treatment of Metastatic Breast Cancer

Clinical trial NCT02555696 · COMPLETED

Trial details

NCT number: NCT02555696
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2012-05-31
Primary completion: 2016-02-28
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.